We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Soaking in it

3 March 2006 By Rob Cox

The toothpaste and soaps giant has struggled of late. So Reuben Mark CEO for 22 years will want to hand over the reins on a high note. One way to do that is to clinch the $13bnplus sale of Pfizer s consumer and OTC business. But this is not without risk for shareholders.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)